Direkt zum Inhalt
Merck
Alle Fotos(1)

Key Documents

View All Documentation

E1600000

Estradiolbenzoat

European Pharmacopoeia (EP) Reference Standard

Synonym(e):

β-Oestradiol-3-benzoat, 1,3,5(10)-Estratrien-3,17β-diol-3-benzoat, 3,17β-Dihydroxy-1,3,5(10)-estratrien-3-benzoat, 3-Benzoyloxy-17β-oestrol

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)

About This Item

Empirische Formel (Hill-System):
C25H28O3
CAS-Nummer:
50-50-0
Molekulargewicht:
376.49
Beilstein:
3107526
MDL-Nummer:
MFCD00003692
UNSPSC-Code:
41116107
PubChem Substanz-ID:
329799012
NACRES:
NA.24

Qualität

pharmaceutical primary standard

API-Familie

estradiol

Hersteller/Markenname

EDQM

mp (Schmelzpunkt)

191-198 °C (lit.)

Anwendung(en)

pharmaceutical (small molecule)

Format

neat

Lagertemp.

2-8°C

SMILES String

[H][C@]12CC[C@]3(C)[C@@H](O)CC[C@@]3([H])[C@]1([H])CCc4cc(OC(=O)c5ccccc5)ccc24

InChI

1S/C25H28O3/c1-25-14-13-20-19-10-8-18(28-24(27)16-5-3-2-4-6-16)15-17(19)7-9-21(20)22(25)11-12-23(25)26/h2-6,8,10,15,20-23,26H,7,9,11-14H2,1H3/t20-,21-,22+,23+,25+/m1/s1

InChIKey

UYIFTLBWAOGQBI-BZDYCCQFSA-N

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Verwandte Kategorien

Allgemeine Beschreibung

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Anwendung

Verwendet in Studien zum allgemeinen Steroidmetabolismus und Basisabklärungen für anaboles Steroid-Screening bei Sportlern

Verpackung

Dieses Produkt wird, wie von der entsprechenden Pharmakopöe geliefert, angeboten. Die aktuellen Mengeneinheiten finden Sie im Referenzsubstanzen-Katalog der EDQM.

Sonstige Hinweise

Sales restrictions may apply.

Ähnliches Produkt

Produkt-Nr.
Beschreibung
Preisangaben

1250008

Estradiol, United States Pharmacopeia (USP) Reference Standard

Y0000314

Estradiol für die Peakidentifizierung, European Pharmacopoeia (EP) Reference Standard

E1620000

Estradiol Hemihydrat, European Pharmacopoeia (EP) Reference Standard

PHR1353

β-Estradiol, Pharmaceutical Secondary Standard; Certified Reference Material

Y0000046

Estradiolvalerat, European Pharmacopoeia (EP) Reference Standard

Y0000852

Estradiolbenzoat für die Systemeignung, European Pharmacopoeia (EP) Reference Standard

1252003

Estradiolcypionat, United States Pharmacopeia (USP) Reference Standard

1251000

Estradiolbenzoat, United States Pharmacopeia (USP) Reference Standard

BP729

Estradiol Hemihydrat, British Pharmacopoeia (BP) Assay Standard

1254009

Estradiolvalerat, United States Pharmacopeia (USP) Reference Standard

1250041

Estradiol-verwandte Verbindung C, United States Pharmacopeia (USP) Reference Standard

1250020

Estradiol-verwandte Verbindung B, United States Pharmacopeia (USP) Reference Standard

1252193

Estradiolcypionat-Systemeignungsmischung, United States Pharmacopeia (USP) Reference Standard

Y0001823

Estradiolvalerat für die Systemeignung, European Pharmacopoeia (EP) Reference Standard

BP396

Estradiol-Benzoat, British Pharmacopoeia (BP) Reference Standard

1254031

Estradiol Valerate Identification Mixture, United States Pharmacopeia (USP) Reference Standard

PHR2228

Estradiol-3-Methyl Ether, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2227

Estradiol-Unreinheit L, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2839

Estradiol-Cypionat, certified reference material, pharmaceutical secondary standard

PHR2857

Estradiol-Valerat, certified reference material, pharmaceutical secondary standard

PHR2858

Estradiol-Benzoat, certified reference material, pharmaceutical secondary standard

PHR2859

Estradiol-verwandte Verbindung C, pharmaceutical secondary standard, certified reference material

Piktogramme

Health hazard
GHS08

Signalwort

Danger

H-Sätze

H351,H360FD

Gefahreneinstufungen

Carc. 2 - Repr. 1B

Lagerklassenschlüssel

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 3

Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

Leider sind derzeit keine COAs für dieses Produkt online verfügbar.

Wenn Sie Hilfe benötigen, wenden Sie sich bitte an Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Kunden haben sich ebenfalls angesehen

Slide 1 of 5

1 of 5

MPP+ iodide ≥98% (HPLC), powder

Sigma-Aldrich

D048

MPP+ iodide

Progesteron ≥99%

Sigma-Aldrich

P0130

Progesteron

Genistein synthetic, ≥98% (HPLC), powder

Sigma-Aldrich

G6649

Genistein

β-Estradiol BioReagent, powder, suitable for cell culture

Sigma-Aldrich

E2758

β-Estradiol

β-Estradiol ≥98%

Sigma-Aldrich

E8875

β-Estradiol

María-Esther Cruz et al.
Alcoholism, clinical and experimental research, 38(6), 1611-1621 (2014-05-14)
Intragastric or intraperitoneal ethanol (EtOH) treatment inhibits reproductive functions in females and male rats. The area of the hypothalamus where these effects take place is unknown. As the participations of the preoptic-anterior hypothalamic area (POA-AHA) in regulating ovulation is asymmetric
Keiko Arakawa et al.
Neuroendocrinology, 100(2-3), 162-177 (2014-10-11)
Exposure to stressors such as foot shock (FS) leads to increased expression of multiple inflammatory factors, including the proinflammatory cytokine interleukin-1 (IL-1) in the brain. Studies have indicated that there are sex differences in stress reactivity, suggesting that the fluctuations
Jesús Olayo-Lortia et al.
The journal of sexual medicine, 11(10), 2428-2438 (2014-07-24)
The multiple partner choice arena (MPCA) is an experimental setup in which male rats display a significant shortening of ejaculation latency, which is the main characteristic of premature ejaculation (PE) in men. Thus, the MPCA is a potential animal model
Camelia M Saffarini et al.
PloS one, 10(3), e0122290-e0122290 (2015-03-24)
Prostate cancer is the most frequent non-cutaneous malignancy in men. There is strong evidence in rodents that neonatal estrogen exposure plays a role in the development of this disease. However, there is little information regarding the effects of estrogen in
Patricia J Allen et al.
Pharmacology, biochemistry, and behavior, 130, 22-33 (2015-01-07)
Creatine is an antioxidant, neuromodulator and key regulator of energy metabolism shown to improve depressive symptoms in humans and animals, especially in females. To better understand the pharmacological effects of creatine, we examined its influence on depression-related hippocampal gene expression
Alle zugehörigen Dokumente anzeigen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.